Warren Buffett's exit from Berkshire Hathaway reignited a debate value investors have circled for years: whether one smaller insurer running the same three-engine compounding model can fill the void, and whether its recent struggles…
Palantir just posted revenue growth above 90% year-over-year with a Rule of 40 score that has Wall Street rubbing its eyes, yet the five-year model tells a far more complicated story than the bull…
Uranium mining sits at the narrow end of the funnel feeding the AI-driven reactor buildout, and three US-listed juniors are racing to fill a supply gap that utilities cannot contract their way out of.…
Both Amgen and Merck write quarterly checks and raise them every year, but only one has the portfolio depth to keep growing that payout through the next brutal round of patent expirations. The answer…
When a nursing home mails a discharge notice for nonpayment while a Medicaid application sits pending at the county office, most families assume they have no choice but to scramble for the money or…
The sales center at a Latitude Margaritaville community has a practiced answer for every question buyers ask, but retirees who moved in years ago say there is one question almost nobody thinks to ask…
Your screener shows Blackstone yielding over 4%, but the actual check that lands in your account follows a completely different logic than that number suggests, and confusing the two has burned plenty of income…
Carl Icahn keeps piling into his own holding company even as its units sink to multi-year lows, and the reasons behind his accumulation are far more complicated than a simple vote of confidence.
Your state of residence on the day you pull from a traditional 401(k) can swing the tax bill by six figures, and a handful of states have quietly built retirement exemptions most people never…